<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27867" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Prosthetic Valve Endocarditis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khalil</surname>
            <given-names>Hassan</given-names>
          </name>
          <aff>The George Washington University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Soufi</surname>
            <given-names>Shadi</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hassan Khalil declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shadi Soufi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27867.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Prosthetic valve endocarditis (PVE) is one type of infectious endocarditis (IE). It accounts for 20% of all cases of endocarditis. It is important to achieve an early diagnosis and initiate treatment as early as possible. This activity reviews this disease's etiology, clinical presentation, and appropriate management. Early diagnosis and treatment initiation improve outcomes and decrease complications and mortality.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Evaluate&#x000a0;the different types of prosthetic valve endocarditis and explain the etiology of each type.</p></list-item><list-item><p>Assess&#x000a0;the clinical presentation and physical findings in patients with prosthetic valve endocarditis.</p></list-item><list-item><p>Identify the appropriate steps in establishing a diagnosis of prosthetic valve endocarditis and guide in selecting appropriate treatment.</p></list-item><list-item><p>Communicate&#x000a0;some interprofessional team strategies that can benefit patients with prosthetic valve endocarditis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27867&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27867">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27867.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Prosthetic valve endocarditis (PVE) is a microbial infection of the endovascular that occurs on parts of a prosthetic valve or the reconstructed native valve of the heart.<xref ref-type="bibr" rid="article-27867.r1">[1]</xref>&#x000a0;PVE accounts for 20% of infective endocarditis. It is the most severe form of infective endocarditis and is associated with high morbidity and mortality.<xref ref-type="bibr" rid="article-27867.r2">[2]</xref>&#x000a0;Based on the time of the disease acquirement, this disease is classified into&#x000a0;2 types: early and late PVE. The early PVE is acquired within&#x000a0;1 year of the surgery, while the late PVE is acquired after&#x000a0;1 year.&#x000a0;The clinical importance of this classification is the distinct microbiological profiles between the former and the latter.</p>
      </sec>
      <sec id="article-27867.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Early PVE occurs due to direct intraoperative contamination or hematogenous spread to the valve in the first days to weeks of the surgical procedure. Paravalvular abscess formation is common in both mechanical and bioprosthetic valves.<xref ref-type="bibr" rid="article-27867.r3">[3]</xref>&#x000a0;After 2 months of surgery and up to 12 months, the infection occurs due to late-onset nosocomial infection or a community-acquired infection.&#x000a0;In the first&#x000a0;2 months after the surgical intervention, Staphylococcus aureus accounts for the highest number of PVE cases, followed by coagulase-negative staphylococci, gram-negative bacilli, and Candida species. In the period of 2 months to 12 months of the surgical intervention, streptococcus, staphylococcus aureus, and coagulase-negative staphylococcus are the most common pathogens. These are followed by enterococcus.<xref ref-type="bibr" rid="article-27867.r4">[4]</xref>&#x000a0;Staphylococcus epidermidis is the most common coagulase-negative staphylococcus in this period and is mostly methicillin-susceptible.<xref ref-type="bibr" rid="article-27867.r5">[5]</xref><xref ref-type="bibr" rid="article-27867.r6">[6]</xref>&#x000a0;Late PVE occurs due to community-acquired infection; pathogens are similar to native valve endocarditis. The most frequent pathogens are streptococci and S. aureus, coagulase-negative staphylococci, and enterococci. Mortality in late PVE is high in patients with multiple comorbidities who acquire endocarditis when admitted to hospitals for other reasons.<xref ref-type="bibr" rid="article-27867.r7">[7]</xref><xref ref-type="bibr" rid="article-27867.r6">[6]</xref>&#x000a0;Culture-negative endocarditis may occur with both early and late PVE. Other etiologies of PVE can be related to nontuberculosis mycobacteria ( Mycobacterium chimera) and enterovirus.<xref ref-type="bibr" rid="article-27867.r8">[8]</xref><xref ref-type="bibr" rid="article-27867.r9">[9]</xref></p>
      </sec>
      <sec id="article-27867.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>PVE is responsible for about 20% of endocarditis cases. It occurs in up to 6% of patients who have valve prostheses.<xref ref-type="bibr" rid="article-27867.r4">[4]</xref>&#x000a0;The epidemiology&#x000a0;of the aortic PVE is different if the valve replacement was done surgically ( surgical aortic valve replacement SAVR) or transcatheter aortic valve replacement (TAVR). In SAVR, the incidence rate of PVE is 6 per 1000 cases.<xref ref-type="bibr" rid="article-27867.r10">[10]</xref>&#x000a0;the rate of PVE is higher in patients with bioprosthetic SAVR than in patients with mechanical SAVR.<xref ref-type="bibr" rid="article-27867.r11">[11]</xref><xref ref-type="bibr" rid="article-27867.r12">[12]</xref>&#x000a0;In TVAR, the incidence rate of PVE in the bioprosthetic valve is similar to the SARV PVE with a bioprosthetic valve.<xref ref-type="bibr" rid="article-27867.r13">[13]</xref>&#x000a0;Healthcare-associated infection is associated with late PVE and occurs due to nosocomial infection when patients are admitted due to other medical conditions or due to exposure in an outpatient facility, such as in infusion centers, nursing homes, or during hemodialysis.<xref ref-type="bibr" rid="article-27867.r4">[4]</xref></p>
      </sec>
      <sec id="article-27867.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In early PVE, the microorganism can directly invade the prosthetic vale intraoperatively due to contamination or spread hematogenous in the initial days to weeks after the procedure. The organisms during the first days after the valve implementation have direct access to the prothesis-annulus interface and the tissue along the suture in the paravalvular area. The organism can adhere to the fibrinogen and fibronectin in the paravalvular area, which causes the formation of abscesses in both mechanical and bioprosthetic valves. In late PVE, the prostheses do not allow the organism to adhere to leaflets as long as there is no evidence of thrombotic material. The sewing ring and sutures become endothelialized after a few months of the valve implementation. Alterations in the valve and the paravalvular surface can lead to the formation of microthrombus, to which the bacterial organisms can adhere and cause an infection.<xref ref-type="bibr" rid="article-27867.r14">[14]</xref></p>
      </sec>
      <sec id="article-27867.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with PVE present with symptoms similar to other types of infectious endocarditis (IE), including fever and chills, shortness of breath, pleuritic chest pains, anorexia, and weight loss. Patients may experience other symptoms such as malaise, headache, myalgias, arthralgias, night sweats, abdominal pain, and cough. Cardiac murmurs are more common in PVE than other types of IE. Splenomegaly and cutaneous manifestations such as petechiae or splinter hemorrhages are other common findings on physical exam. Petechiae are observed in up to 40 percent of patients; they can present as skin findings on an extremity or mucosal surfaces of the palate and conjunctivae. Findings on nail beds can include Splinter hemorrhages, which appear as red to brown lines that are non-blanching under the nail bed. Other less common clinical manifestations are Janeway lesions, which are non-tender erythematous macules on the palms and soles. Osler nodes are subcutaneous violaceous nodules, mainly on the pads of the fingers and toes. Additionally, Roth spots exudative, edematous hemorrhagic lesions of the retina with pale centers.</p>
      </sec>
      <sec id="article-27867.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A workup should always involve obtaining blood cultures when a patient is suspected of having PVE due to clinical manifestations. Bacteremia in a febrile patient with a history of prosthetic valve replacement raises the probability of the PVE.&#x000a0;Three blood cultures from different sites are required. A transthoracic echocardiogram (TTE) should follow this.<xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;The modified Duke criteria are accepted criteria to establish the diagnosis of PVE.<xref ref-type="bibr" rid="article-27867.r16">[16]</xref>&#x000a0;Transesophageal echo (TEE) is recommended when TTE fails to make the diagnosis.<xref ref-type="bibr" rid="article-27867.r17">[17]</xref>&#x000a0;If the initial TEE is negative, repeating it in 3-5 days is recommended when the clinical suspicion is high for PVE. As&#x000a0;shielding from the prosthesis prevents adequate images of TTE, TEE provides better diagnoses of PVE.<xref ref-type="bibr" rid="article-27867.r18">[18]</xref><xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;TEE's role is to help identify vegetation, characterize the valve dysfunction, identify the spread of infection in the periprosthetic area, determine the preoperative prognosis and timing for surgery, and follow up on PVE after management.<xref ref-type="bibr" rid="article-27867.r18">[18]</xref>&#x000a0;TEE has better sensitivity than TTE in diagnosing infectious endocarditis, especially PVE.<xref ref-type="bibr" rid="article-27867.r19">[19]</xref>&#x000a0;TEE should be done if there is suspicion about intracardiac complications in patients with positive IE on TTE.<xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;TEE should be repeated if there are any clinical features of the development of new intracardiac complications.<xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;Other diagnostic modalities may be required as part of the workup for patients with PVE; a chest X-ray can be ordered to evaluate lung infiltrates, and an electrocardiogram can be ordered to evaluate PR prolongation and possible AV blocks.</p>
        <p>Cardiac computed tomography angiogram (CTA) can be used to diagnose PVE if the TEE fails to provide the diagnosis; cardiac CT is better than TEE for detecting perivalvular abscess; CTA can be used as the next step in diagnosis for patients who have negative TTE and have contraindications to perform TEE.<xref ref-type="bibr" rid="article-27867.r20">[20]</xref><xref ref-type="bibr" rid="article-27867.r21">[21]</xref><xref ref-type="bibr" rid="article-27867.r22">[22]</xref>&#x000a0;18F-FDG PET/CT can be used to diagnose PVE if TTE/TEE fails to make the diagnosis and there is a high probability of the infection. It&#x000a0;improves the diagnostic accuracy of the modified&#x000a0;Duke criteria&#x000a0;and yields high diagnostic performance.<xref ref-type="bibr" rid="article-27867.r23">[23]</xref>&#x000a0;Promising data showed 18F-FDG PET/CT to help as a follow-up modality after completing IE antibiotic treatment.<xref ref-type="bibr" rid="article-27867.r24">[24]</xref><xref ref-type="bibr" rid="article-27867.r25">[25]</xref>&#x000a0;Magnetic resonance imaging (MRI) of the brain is considered the best diagnostic tool when septic emboli are suspected in the brain. CT&#x000a0;of the chest and abdomen can also be considered when septic emboli are suspected.<xref ref-type="bibr" rid="article-27867.r25">[25]</xref></p>
      </sec>
      <sec id="article-27867.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The valvular vegetations associated with PVE are usually larger than those found in native valve endocarditis (NVE). For the antibiotics to penetrate the total vegetation, they should be used in dosages that result in maximum, non-toxic serum concentrations.<xref ref-type="bibr" rid="article-27867.r1">[1]</xref>&#x000a0;When starting the treatment for a patient with PVE, it is required to identify the causing microorganism, select the appropriate antibiotic, evaluate for any complications of the endocarditis, and evaluate the need for surgical intervention if the antibiotics treatment fails, the infection causes a valvular abscess. Empiric treatment with antibiotics should be started after 3 blood cultures are obtained. This treatment should consider coverage of gram-positive and gram-negative bacteria. This empiric treatment should include vancomycin, gentamycin, and anti-pseudomonal carbapenem or cefepime. When the causing organism is identified, treatment should be tailored towards the coverage of this causative agent. American Heart Association recommends at least&#x000a0;6 weeks of antibiotic treatment.<xref ref-type="bibr" rid="article-27867.r25">[25]</xref><xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;When PVE is caused by staphylococcus, AHA recommends starting triple antibiotical treatment.<xref ref-type="bibr" rid="article-27867.r25">[25]</xref><xref ref-type="bibr" rid="article-27867.r26">[26]</xref>&#x000a0;In the staphylococcus-induced PVE, either <italic toggle="yes">S. aureus</italic> or <italic toggle="yes">S. epidermidis</italic>, the susceptibility to methicillin is the main consideration when selecting combination therapy. When PVE is caused by methicillin-sensitive staphylococcus, the triple antibiotic regimen includes nafcillin or oxacillin (total of&#x000a0;6 weeks) combined with both gentamicin (which is given for the first 2 weeks of treatment only) and rifampin (total of&#x000a0;6 weeks of treatment). If the patient reports being allergic to penicillin without evidence of anaphylaxis, a first-generation cephalosporin should be the next choice.</p>
        <p>For methicillin-resistant staphylococcus, vancomycin should be combined with gentamycin and rifampin. If the bacteria is resistant to gentamycin, another aminoglycoside should be selected depending on the antibiotic susceptibilities.<xref ref-type="bibr" rid="article-27867.r25">[25]</xref>&#x000a0;A fluoroquinolone can be an alternative to the aminoglycoside in case of pan resistance to all aminoglycosides.<xref ref-type="bibr" rid="article-27867.r27">[27]</xref>&#x000a0;Rifampin uniquely affects staphylococcus invasion of foreign bodies and is used in staphylococcus-induced IE.<xref ref-type="bibr" rid="article-27867.r28">[28]</xref>&#x000a0;In streptococcal-induced PVE, combining a beta-lactam antibiotic and an aminoglycoside is the treatment of choice. This combination provides a synergistic killing of the causative bacteria.<xref ref-type="bibr" rid="article-27867.r17">[17]</xref>&#x000a0;If a penicillin-susceptible Streptococcus causes the PVE, the penicillin-gentamycin combination is recommended. For&#x000a0;penicillin-allergic patients, vancomycin or cephalosporine are the choices. If the patient's penicillin allergy is not severe (does not include anaphylaxis), a cephalosporin should be used first. If the aminoglycoside is contraindicated, PVE can be treated with a single agent (penicillin, cephalosporine, or vancomycin). If the streptococcus resists penicillin, an aminoglycoside can be used alone for treatment.<xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;If the organism is resistant to aminoglycoside, recommendations are for treatment with vancomycin as a single agent. In enterococcal-induced PVE, the combination of a cell wall-active agent (penicillin, ampicillin, or vancomycin) and an aminoglycoside (gentamycin or streptomycin)&#x000a0;is considered. In penicillin allergy, vancomycin is a better alternative than cephalosporine combined with an aminoglycoside, as cephalosporins are ineffective against enterococcus.<xref ref-type="bibr" rid="article-27867.r29">[29]</xref>&#x000a0;In the setting of aminoglycoside resistance, the enterococcus PVE should be treated with a cell wall-active agent (penicillin, ampicillin, or vancomycin) alone for a longer period (8&#x000a0;to 12) weeks.<xref ref-type="bibr" rid="article-27867.r30">[30]</xref>&#x000a0;In the setting of vancomycin-resistant&#x000a0;<italic toggle="yes">Enterococcus faecium</italic>&#x000a0;(VRE), daptomycin and linezolid&#x000a0;are considered acceptable choices for treatment.<xref ref-type="bibr" rid="article-27867.r31">[31]</xref></p>
        <p>When PVE is caused by Haemophilus, Aggregatibacter (previously Actinobacillus), Cardiobacterium, Eikenella, or Kingella (HACEK), third-generation cephalosporins are usually the first line of treatment and used for a total treatment period of&#x000a0;6 weeks.&#x000a0;Ampicillin can be used if the organism shows sensitivity to the cultures. A fluoroquinolone can be used to treat an allergy to cephalosporins and ampicillin.<xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;Treatment of gram-negative bacilli-induced PVE is usually combination therapy with a beta-lactam (penicillins, cephalosporins, or carbapenems) and either a fluoroquinolone or an aminoglycoside. The recommended duration of treatment is 6 weeks.<xref ref-type="bibr" rid="article-27867.r25">[25]</xref>&#x000a0;For patients with culture-negative PVE onset &#x02264;1 year, the antibiotics coverage should consider the possibility of infection due to staphylococci, enterococci, and aerobic gram-negative bacilli. The antibiotic combination should include vancomycin, gentamicin, cefepime, and rifampin per AHA recommendations.<xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;AHA recommends patients with culture-negative PVE onset &#x0003e;1 year after surgery receive infection coverage due to staphylococci, viridans group streptococci, enterococci, and HACEK organisms. The empiric combination should include vancomycin and ceftriaxone.<xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;AHA recommends repeating 2 blood cultures every 24&#x000a0;to 48 hours till blood cultures are negative and starting the count of antibiotics treatment days after the first negative blood culture is achieved.</p>
        <p>Early surgical intervention for PVE is indicated if:<xref ref-type="bibr" rid="article-27867.r15">[15]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>The patient develops heart failure due to valve dehiscence, the development of intracardiac fistula, or the presence of severe prosthetic valve dysfunction.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The presence of persistent bacteremia 5 to 7 days after the appropriate antibiotic regimen, with other bacteremia sources, is excluded.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Evidence of heart block, development of abscess (annular or aortic), or presence of destructive penetrating lesions</p>
          </list-item>
          <list-item>
            <p>Fungi or highly resistant bacterial organisms cause the PVE.</p>
          </list-item>
        </list>
        <p>Early surgery is reasonable in PVE in the following scenarios: developing recurrent emboli despite the appropriate antibiotic treatment, relapsing PVE, or large mobile vegetations &#x0003e;10 mm.<xref ref-type="bibr" rid="article-27867.r15">[15]</xref>&#x000a0;Surgical intervention decreases mortality when performed on patients with PVE who develop heart failure.<xref ref-type="bibr" rid="article-27867.r32">[32]</xref>&#x000a0;Paravalvular PVE invasion can manifest as a complete heart block, annular or aortic abscess, destructive penetrating lesions, or an intracardiac fistula. These complications require early complex reconstructive surgery, improving the survival rate by 80%.<xref ref-type="bibr" rid="article-27867.r33">[33]</xref>&#x000a0;S. aureus PVE is associated with high mortality, and often, early surgery is indicated when complications are present. Such an early surgical approach was associated with decreased mortality in these patients. Other&#x000a0;organisms that may require early surgical intervention are gram-negative (non-HACEK) microorganisms (&#x000a0;<italic toggle="yes">Pseudomonas aeruginosa</italic>&#x000a0;and multidrug-resistant gram-negative bacilli), multidrug-resistant enterococci, and fungi.<xref ref-type="bibr" rid="article-27867.r34">[34]</xref></p>
        <p>After the surgical intervention is completed,&#x000a0;6 weeks of intravenous antibiotics are recommended if the intraoperative valve culture is positive.<xref ref-type="bibr" rid="article-27867.r35">[35]</xref></p>
      </sec>
      <sec id="article-27867.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for PVE include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Native valve endocarditis: Patients usually have a clinical picture similar to PVE patients.</p>
          </list-item>
          <list-item>
            <p>Atrial myxoma: Patients present with constitutional symptoms secondary to cytokine release or may have systemic disease secondary to the embolic phenomenon.</p>
          </list-item>
          <list-item>
            <p>Libman-Sacks endocarditis: Patients are commonly asymptomatic and have a history suggestive of a diagnosis of systemic lupus erythematosus SLE.</p>
          </list-item>
          <list-item>
            <p>Nonbacterial thrombotic endocarditis (NBTE): Endocarditis is caused by sterile vegetation deposition on cardiac valves. NBTE can be caused by pancreatic, lung, and colon tumors or from SLE or tuberculosis.<xref ref-type="bibr" rid="article-27867.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p>Rheumatic fever: Jones criteria make the diagnosis: evidence of carditis, polyarthritis, chorea, erythema marginatum, subcutaneous nodules, and evidence of preceding streptococcal infection.<xref ref-type="bibr" rid="article-27867.r37">[37]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27867.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Despite the appropriate diagnosis and use of surgical treatment in PVE, morbidity and mortality remain high; PVE carries the highest mortality rates compared to other types of IE. The strongest predictors of mortality were persistent bacteremia, heart failure, intracardiac abscess, and stroke development.<xref ref-type="bibr" rid="article-27867.r4">[4]</xref>&#x000a0;Persistent bacteremia and healthcare-associated infection are associated with&#x000a0;<italic toggle="yes">S&#x000a0;</italic><italic toggle="yes">aureus-</italic>induced&#x000a0;IE.<xref ref-type="bibr" rid="article-27867.r38">[38]</xref>&#x000a0;<italic toggle="yes">S. aureus</italic> is associated with high mortality in both PVE and native valve endocarditis.<xref ref-type="bibr" rid="article-27867.r39">[39]</xref>&#x000a0;Healthcare-associated PVE is another predictor of high in-hospital mortality.<xref ref-type="bibr" rid="article-27867.r40">[40]</xref>&#x000a0;Other predictors for higher mortality are large vegetation, poor surgical candidacy, positive valve culture, embolization, and diabetes mellitus.<xref ref-type="bibr" rid="article-27867.r41">[41]</xref><xref ref-type="bibr" rid="article-27867.r42">[42]</xref></p>
      </sec>
      <sec id="article-27867.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most common cardiac complication of PVE is heart failure. This can result from prosthetic valve dehiscence, which leads to valvular insufficiency or myocardial infarction from emboli.<xref ref-type="bibr" rid="article-27867.r43">[43]</xref>&#x000a0;Other cardiac complications are perivalvular abscess formation, intracardiac fistula, and pericarditis.<xref ref-type="bibr" rid="article-27867.r44">[44]</xref>&#x000a0;Non-cardiac complications are usually a result of an embolic event, metastatic abscess formation, or a mycotic aneurysm. Neurologic complications are stroke (due to an embolus), seizure (abscess or emboli), brain abscess formation, aseptic meningitis, acute encephalopathy, cerebral hemorrhage due to ruptured mycotic aneurysm, or meningoencephalitis.<xref ref-type="bibr" rid="article-27867.r45">[45]</xref><xref ref-type="bibr" rid="article-27867.r46">[46]</xref>&#x000a0;Renal complications are renal infarction due to emboli, renal abscess, glomerulonephritis (due to immunoglobulins and complement deposition in the glomerular membrane), and acute interstitial nephritis. All these complications may present as acute renal failure.<xref ref-type="bibr" rid="article-27867.r47">[47]</xref>&#x000a0;Pulmonary complications occur due to right heart PVE; vegetations of the tricuspid or pulmonary valve can lead to embolization, which results in lung abscess, pneumonia, pleural effusion, or pneumothorax. Other complications are osteomyelitis, septic arthritis, persistent bacteremia, or candidemia in fungal PVE.<xref ref-type="bibr" rid="article-27867.r48">[48]</xref>&#x000a0;Mortality remains a serious concern after PVE despite appropriate treatment and surgical interventions.<xref ref-type="bibr" rid="article-27867.r4">[4]</xref></p>
      </sec>
      <sec id="article-27867.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>To manage patients with VPE, the treating team must include the right interprofessional consultants. Early involvement of a cardiologist is essential to make the correct diagnosis, review the imaging studies, and give recommendations for the treatment plan. An infectious disease consult is necessary to direct the initial antibiotics treatment, review the cultures, and redirect the treatment according to the susceptibility results. Involving the radiologist in interpreting the imaging studies is an important step in managing patients with PVE. Some patients may require advanced imaging studies, and the radiologist recommends and directly chooses the&#x000a0;appropriate type of imaging studies indicated to&#x000a0;achieve the diagnosis. A cardiovascular surgeon should be part of the management team for patients with PVE. The cardiovascular surgeon needs to review the imaging studies, follow the patient's treatment progress, and follow the patient's blood culture response to the antibiotic treatment to determine the need for surgical intervention. A pharmacist's early involvement is important in managing PVE patients, directing the antibiotics treatment during hospitalization, checking the drug interactions, and following the patient's treatment course after discharge.</p>
      </sec>
      <sec id="article-27867.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Endocarditis is an infection usually caused by bacteria or fungi and affects the heart's inner layer, including the heart's valves. The causative organism is most likely a bacteria but can also include some fungi that get to the heart through the bloodstream.&#x000a0;PVE is&#x000a0;1 type of endocarditis that affects the replaced prosthetic valve.&#x000a0;Getting infected heart valves causes damage to the valve and, hence, malfunction, which can cause major complications. Early treatment is necessary to prevent bad outcomes. Having surgery for a heart valve increases the risk of infection. Those who intravenously abuse drugs&#x000a0;are at higher risk of this type of infection.&#x000a0;</p>
        <p>The patient should return to the emergency room if the patient experiences any of the following symptoms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tiredness that persists for 2 to 3 days</p>
          </list-item>
          <list-item>
            <p>Decreased exercise tolerance</p>
          </list-item>
          <list-item>
            <p>Chest pain or shortness of breath</p>
          </list-item>
          <list-item>
            <p>Fever over 100.4&#x000a0;degrees F (38.0&#x000a0;degrees C)</p>
          </list-item>
          <list-item>
            <p>Extensive sweats, especially at night</p>
          </list-item>
          <list-item>
            <p>Palpitations</p>
          </list-item>
          <list-item>
            <p>Fainting</p>
          </list-item>
          <list-item>
            <p>Trouble speaking</p>
          </list-item>
          <list-item>
            <p>Weakness in any extremity or face</p>
          </list-item>
          <list-item>
            <p>Spots on fingernails, fingertips, whites of the eyes, or other skin areas</p>
          </list-item>
          <list-item>
            <p>Symptoms of a stroke include trouble speaking or inability to move&#x000a0;1 side of your body</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27867.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PVE is associated with high morbidity and mortality. A comprehensive healthcare team must be cautious in the workup and treatment of this disease.&#x000a0;Treatment of PVE needs to be started early, in an inpatient setting, and monitored by an interdisciplinary team of physicians, nurses, and&#x000a0;pharmacists to ensure the appropriate treatment and prevent complications as treatment is usually extended over&#x000a0;6 to&#x000a0;8 weeks, patients complete treatment in an outpatient setting, at a short-term nursing facility, or home with home&#x000a0;intravenous infusion. When a patient presents with suspected PVE, the physician starts the empiric antibiotics treatment, initiates the appropriate workup for confirmation of diagnosis, and identifies the causative organism. Antibiotics should be tailored to target the organism based on susceptibility results.&#x000a0;Usually, physicians&#x000a0;follow the necessary laboratory testing to prevent any possible renal or liver toxicity and monitor for signs or symptoms of PVE-related complications. The pharmacist has to check the antibiotic regimen, monitor for any possible drug-to-drug interaction, and monitor any possible toxicity. Nurses are responsible for appropriately administering the medications and monitoring for possible side effects during the hospital stay.</p>
        <p>After discharge from the hospital, the team is responsible for appropriate follow-up on the patient&#x02019;s adherence to treatment and monitoring possible side effects.&#x000a0;The Doctor&#x000a0;has to order appropriate laboratory tests to monitor possible toxicity and monitor drug levels in coordination with the pharmacist. The home visiting nurse ensures adherence, evaluates for appropriate intravenous administration of antibiotics, monitors the&#x000a0;intravenous line side, monitors for any adverse reactions, and evaluates the patient for any possible signs or symptoms of PVE-related complications. Pharmacists and nurses should inform the clinician if medication compliance concerns a certain patient. This also includes drug adverse reactions or&#x000a0;changes in a household environment. This comprehensive interprofessional team effort is needed to ensure high-quality patient care and to have the maximum benefits of the regimen.</p>
      </sec>
      <sec id="article-27867.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27867&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27867">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/prosthetic-valve-endocarditis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27867">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27867/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27867">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27867.s16">
        <title>References</title>
        <ref id="article-27867.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piper</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>K&#x000f6;rfer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Horstkotte</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic valve endocarditis.</article-title>
            <source>Heart</source>
            <year>2001</year>
            <month>May</month>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>590</fpage>
            <page-range>590-3</page-range>
            <pub-id pub-id-type="pmid">11303018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Holzmann</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Franco-Cereceda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sartipy</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement.</article-title>
            <source>Circulation</source>
            <year>2017</year>
            <month>Jul</month>
            <day>18</day>
            <volume>136</volume>
            <issue>3</issue>
            <fpage>329</fpage>
            <page-range>329-331</page-range>
            <pub-id pub-id-type="pmid">28716834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carpenter</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Perivalvular extension of infection in patients with infectious endocarditis.</article-title>
            <source>Rev Infect Dis</source>
            <year>1991</year>
            <season>Jan-Feb</season>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>127</fpage>
            <page-range>127-38</page-range>
            <pub-id pub-id-type="pmid">2017612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Athan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Olaison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Par&#x000e9;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Almirante</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rizzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Naber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Logar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tattevin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Iarussi</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Selton-Suty</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Casab&#x000e9;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Cabell</surname>
                <given-names>CH</given-names>
              </name>
              <collab>International Collaboration on Endocarditis-Prospective Cohort Study Investigators</collab>
            </person-group>
            <article-title>Contemporary clinical profile and outcome of prosthetic valve endocarditis.</article-title>
            <source>JAMA</source>
            <year>2007</year>
            <month>Mar</month>
            <day>28</day>
            <volume>297</volume>
            <issue>12</issue>
            <fpage>1354</fpage>
            <page-range>1354-61</page-range>
            <pub-id pub-id-type="pmid">17392239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hoen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cabell</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stryjewski</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Anguera</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Commerford</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Oyonarte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Selton-Suty</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Almirante</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sexton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <collab>International Collaboration on Endocarditis-Prospective Cohort Study Group</collab>
            </person-group>
            <article-title>Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study.</article-title>
            <source>Heart</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>95</volume>
            <issue>7</issue>
            <fpage>570</fpage>
            <page-range>570-6</page-range>
            <pub-id pub-id-type="pmid">18952633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Burner</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Fealey</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Tazelaar</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Orszulak</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Baddour</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic valve endocarditis: clinicopathological correlates in 122 surgical specimens from 116 patients (1985-2004).</article-title>
            <source>Cardiovasc Pathol</source>
            <year>2011</year>
            <season>Jan-Feb</season>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-35</page-range>
            <pub-id pub-id-type="pmid">19926308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rivas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moya</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de G&#x000f3;rgolas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martinell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez Guerrero</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>The impact of hospital-acquired infections on the microbial etiology and prognosis of late-onset prosthetic valve endocarditis.</article-title>
            <source>Chest</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>128</volume>
            <issue>2</issue>
            <fpage>764</fpage>
            <page-range>764-71</page-range>
            <pub-id pub-id-type="pmid">16100165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blumental</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reynders</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Willems</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biarent</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Duttman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lepage</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vergison</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Enteroviral infection of a cardiac prosthetic device.</article-title>
            <source>Clin Infect Dis</source>
            <year>2011</year>
            <month>Mar</month>
            <day>15</day>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>710</fpage>
            <page-range>710-6</page-range>
            <pub-id pub-id-type="pmid">21367724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achermann</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>R&#x000f6;ssle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deggim</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kuster</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zimmermann</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Bloemberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hombach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hasse</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera.</article-title>
            <source>J Clin Microbiol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>1769</fpage>
            <page-range>1769-73</page-range>
            <pub-id pub-id-type="pmid">23536407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d8;stergaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Valeur</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ihlemann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bundgaard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gislason</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Torp-Pedersen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bruun</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>S&#x000f8;ndergaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>K&#x000f8;ber</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fosb&#x000f8;l</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Incidence of infective endocarditis among patients considered at high risk.</article-title>
            <source>Eur Heart J</source>
            <year>2018</year>
            <month>Feb</month>
            <day>14</day>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>623</fpage>
            <page-range>623-629</page-range>
            <pub-id pub-id-type="pmid">29244073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hammermeister</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Oprian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rahimtoola</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>1152</fpage>
            <page-range>1152-8</page-range>
            <pub-id pub-id-type="pmid">11028464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Holzmann</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Franco-Cereceda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sartipy</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.</article-title>
            <source>Eur Heart J</source>
            <year>2016</year>
            <month>Sep</month>
            <day>07</day>
            <volume>37</volume>
            <issue>34</issue>
            <fpage>2658</fpage>
            <page-range>2658-67</page-range>
            <pub-id pub-id-type="pmid">26559386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butt</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Ihlemann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>S&#x000f8;ndergaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Havers-Borgersen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gislason</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Torp-Pedersen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>K&#x000f8;ber</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fosb&#x000f8;l</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Risk of Infective Endocarditis&#x000a0;After Transcatheter Aortic&#x000a0;Valve&#x000a0;Replacement.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Apr</month>
            <day>09</day>
            <volume>73</volume>
            <issue>13</issue>
            <fpage>1646</fpage>
            <page-range>1646-1655</page-range>
            <pub-id pub-id-type="pmid">30947917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahesh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Caputo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic valve endocarditis.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>1151</fpage>
            <page-range>1151-8</page-range>
            <pub-id pub-id-type="pmid">16122521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baddour</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Bayer</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Tleyjeh</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Rybak</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Barsic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Gewitz</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Levison</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bolger</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Steckelberg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Baltimore</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taubert</surname>
                <given-names>KA</given-names>
              </name>
              <collab>American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council</collab>
            </person-group>
            <article-title>Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Oct</month>
            <day>13</day>
            <volume>132</volume>
            <issue>15</issue>
            <fpage>1435</fpage>
            <page-range>1435-86</page-range>
            <pub-id pub-id-type="pmid">26373316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Durack</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Lukes</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Bright</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.</article-title>
            <source>Am J Med</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>200</fpage>
            <page-range>200-9</page-range>
            <pub-id pub-id-type="pmid">8154507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gould</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Foweraker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Sandoe</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Spry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Working Party of the British Society for Antimicrobial Chemotherapy</surname>
              </name>
            </person-group>
            <article-title>Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-89</page-range>
            <pub-id pub-id-type="pmid">22086858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stewart</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The diagnosis of prosthetic valve endocarditis by echocardiography.</article-title>
            <source>Semin Thorac Cardiovasc Surg</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-12</page-range>
            <pub-id pub-id-type="pmid">7893839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roe</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heinle</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Kisslo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Sexton</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria.</article-title>
            <source>Am Heart J</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>139</volume>
            <issue>6</issue>
            <fpage>945</fpage>
            <page-range>945-51</page-range>
            <pub-id pub-id-type="pmid">10827373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koneru</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Oldan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Betancor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Popovic</surname>
                <given-names>ZB</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Shrestha</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pettersson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bolen</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Role of preoperative cardiac CT in the evaluation of infective endocarditis: comparison with transesophageal echocardiography and surgical findings.</article-title>
            <source>Cardiovasc Diagn Ther</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>439</fpage>
            <page-range>439-449</page-range>
            <pub-id pub-id-type="pmid">30214859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rouzet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brochet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Imaging of Infective Endocarditis, Echo and Beyond.</article-title>
            <source>Curr Infect Dis Rep</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>8</fpage>
            <pub-id pub-id-type="pmid">28233189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Cardiac Computed Tomography With Transesophageal Echocardiography for Identifying Vegetation and Intracardiac Complications in Patients With Infective Endocarditis in the Era of 3-Dimensional Images.</article-title>
            <source>Circ Cardiovasc Imaging</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>e006986</fpage>
            <pub-id pub-id-type="pmid">29555833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pizzi</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Roque</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Hidalgo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cu&#x000e9;llar-Calabria</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ferreira-Gonz&#x000e1;lez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e0;lez-Alujas</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Oristrell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gracia-S&#x000e1;nchez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Palomares</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gali&#x000f1;anes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maisterra-Santos</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Garcia-Dorado</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Castell-Conesa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Almirante</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aguad&#x000e9;-Bruix</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Sep</month>
            <day>22</day>
            <volume>132</volume>
            <issue>12</issue>
            <fpage>1113</fpage>
            <page-range>1113-26</page-range>
            <pub-id pub-id-type="pmid">26276890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pizzi</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Roque</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cu&#x000e9;llar-Calabria</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Hidalgo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ferreira-Gonz&#x000e1;lez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Alujas</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Igual-Barcel&#x000f3;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garcia-Dorado</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Almirante</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Castell-Conesa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Escobar Amores</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aguad&#x000e9;-Bruix</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title><sup>18</sup>F-FDG-PET/CTA of Prosthetic Cardiac&#x000a0;Valves and Valve-Tube Grafts: Infective Versus Inflammatory Patterns.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>10</issue>
            <fpage>1224</fpage>
            <page-range>1224-1227</page-range>
            <pub-id pub-id-type="pmid">27639767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Antunes</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bongiorni</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Casalta</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Del Zotti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dulgheru</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>El Khoury</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Plonska-Gosciniak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roos-Hesselink</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Snygg-Martin</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Thuny</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tornos Mas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vilacosta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <collab>ESC Scientific Document Group</collab>
            </person-group>
            <article-title>2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).</article-title>
            <source>Eur Heart J</source>
            <year>2015</year>
            <month>Nov</month>
            <day>21</day>
            <volume>36</volume>
            <issue>44</issue>
            <fpage>3075</fpage>
            <page-range>3075-3128</page-range>
            <pub-id pub-id-type="pmid">26320109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drinkovi&#x00107;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Pottumarthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>MacCulloch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>820</fpage>
            <page-range>820-5</page-range>
            <pub-id pub-id-type="pmid">14519677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chuard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vaudaux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Waldvogel</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Lew</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1991</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>12</issue>
            <fpage>2611</fpage>
            <page-range>2611-6</page-range>
            <pub-id pub-id-type="pmid">1810196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucet</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rohner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Auckenthaler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Waldvogel</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Lew</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1990</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>2312</fpage>
            <page-range>2312-7</page-range>
            <pub-id pub-id-type="pmid">2128441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rice</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Eliopoulos</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Karchmer</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Enterococcal endocarditis: a comparison of prosthetic and native valve disease.</article-title>
            <source>Rev Infect Dis</source>
            <year>1991</year>
            <season>Jan-Feb</season>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">2017607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GERACI</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>MARTIN</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases.</article-title>
            <source>Circulation</source>
            <year>1954</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>173</fpage>
            <page-range>173-94</page-range>
            <pub-id pub-id-type="pmid">13182750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of Enterococcus faecalis prosthetic valve endocarditis with linezolid.</article-title>
            <source>Clin Infect Dis</source>
            <year>2002</year>
            <month>Oct</month>
            <day>01</day>
            <volume>35</volume>
            <issue>7</issue>
            <fpage>902</fpage>
            <page-range>902-4</page-range>
            <pub-id pub-id-type="pmid">12228838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sevilla</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vilacosta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sarri&#x000e1;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pozo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Revilla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varvaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>del Palacio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>San Rom&#x000e1;n</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Clinical significance of congestive heart failure in prosthetic valve endocarditis. A multicenter study with 257 patients.</article-title>
            <source>Rev Esp Cardiol (Engl Ed)</source>
            <year>2013</year>
            <month>May</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>384</fpage>
            <page-range>384-90</page-range>
            <pub-id pub-id-type="pmid">24775821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jault</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gandjbakhch</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chastre</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Levasseur</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Bors</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gibert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pavie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cabrol</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic valve endocarditis with ring abscesses. Surgical management and long-term results.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>105</volume>
            <issue>6</issue>
            <fpage>1106</fpage>
            <page-range>1106-13</page-range>
            <pub-id pub-id-type="pmid">8501938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chirouze</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cabell</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Khayat</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Olaison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Abrutyn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Eykyn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Selton-Suty</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hoen</surname>
                <given-names>B</given-names>
              </name>
              <collab>International Collaboration on Endocarditis Study Group</collab>
            </person-group>
            <article-title>Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database.</article-title>
            <source>Clin Infect Dis</source>
            <year>2004</year>
            <month>May</month>
            <day>01</day>
            <volume>38</volume>
            <issue>9</issue>
            <fpage>1323</fpage>
            <page-range>1323-7</page-range>
            <pub-id pub-id-type="pmid">15127349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hoen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thuny</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vilacosta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Moreillon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Jesus Antunes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thilen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Lekakis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lengyel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Naber</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Nihoyannopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moritz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <collab>ESC Committee for Practice Guidelines</collab>
            </person-group>
            <article-title>Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.</article-title>
            <source>Eur Heart J</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>19</issue>
            <fpage>2369</fpage>
            <page-range>2369-413</page-range>
            <pub-id pub-id-type="pmid">19713420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lopez</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Nonbacterial thrombotic endocarditis: a review.</article-title>
            <source>Am Heart J</source>
            <year>1987</year>
            <month>Mar</month>
            <volume>113</volume>
            <issue>3</issue>
            <fpage>773</fpage>
            <page-range>773-84</page-range>
            <pub-id pub-id-type="pmid">3548296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Rheumatic heart disease.</article-title>
            <source>Curr Opin Cardiol</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>126</fpage>
            <page-range>126-30</page-range>
            <pub-id pub-id-type="pmid">8736683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hoen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cabell</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Abrutyn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rubinstein</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Spelman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Barsic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Anstrom</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Wray</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fortes</surname>
                <given-names>CQ</given-names>
              </name>
              <name>
                <surname>Anguera</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Athan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>van der Meer</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Bayer</surname>
                <given-names>AS</given-names>
              </name>
              <collab>ICE Investigators</collab>
            </person-group>
            <article-title>Staphylococcus aureus endocarditis: a consequence of medical progress.</article-title>
            <source>JAMA</source>
            <year>2005</year>
            <month>Jun</month>
            <day>22</day>
            <volume>293</volume>
            <issue>24</issue>
            <fpage>3012</fpage>
            <page-range>3012-21</page-range>
            <pub-id pub-id-type="pmid">15972563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Anstrom</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Abrutyn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Hoen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Olaison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stafford</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mestres</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cabell</surname>
                <given-names>CH</given-names>
              </name>
              <collab>International Collaboration on Endocarditis Investigators</collab>
            </person-group>
            <article-title>The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort.</article-title>
            <source>Am Heart J</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>150</volume>
            <issue>5</issue>
            <fpage>1086</fpage>
            <page-range>1086-91</page-range>
            <pub-id pub-id-type="pmid">16291003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Cabell</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Kuniholm</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Engemann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sexton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Early predictors of in-hospital death in infective endocarditis.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Apr</month>
            <day>13</day>
            <volume>109</volume>
            <issue>14</issue>
            <fpage>1745</fpage>
            <page-range>1745-9</page-range>
            <pub-id pub-id-type="pmid">15037538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cabell</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Pond</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Durack</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lukes</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Sexton</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>The risk of stroke and death in patients with aortic and mitral valve endocarditis.</article-title>
            <source>Am Heart J</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>142</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-80</page-range>
            <pub-id pub-id-type="pmid">11431660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hill</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Herijgers</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Claus</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vanderschueren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Herregods</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Peetermans</surname>
                <given-names>WE</given-names>
              </name>
            </person-group>
            <article-title>Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study.</article-title>
            <source>Eur Heart J</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-203</page-range>
            <pub-id pub-id-type="pmid">17158121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Millaire</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Belle</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Groote</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leroy</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ducloux</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Obstruction of the left main coronary ostium due to an aortic vegetation: survival after early surgery.</article-title>
            <source>Clin Infect Dis</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>192</fpage>
            <page-range>192-3</page-range>
            <pub-id pub-id-type="pmid">8825007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ben Ismail</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hannachi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Abid</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kaabar</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Roug&#x000e9;</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic valve endocarditis. A survey.</article-title>
            <source>Br Heart J</source>
            <year>1987</year>
            <month>Jul</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <page-range>72-7</page-range>
            <pub-id pub-id-type="pmid">3620246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Snygg-Martin</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Gustafsson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rosengren</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alsi&#x000f6;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ackerholm</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Olaison</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers.</article-title>
            <source>Clin Infect Dis</source>
            <year>2008</year>
            <month>Jul</month>
            <day>01</day>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-30</page-range>
            <pub-id pub-id-type="pmid">18491965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruttmann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Willeit</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ulmer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chevtchik</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>H&#x000f6;fer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Poewe</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laufer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Neurological outcome of septic cardioembolic stroke after infective endocarditis.</article-title>
            <source>Stroke</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>2094</fpage>
            <page-range>2094-9</page-range>
            <pub-id pub-id-type="pmid">16794213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conlon</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Jefferies</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Krigman</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Sexton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Predictors of prognosis and risk of acute renal failure in bacterial endocarditis.</article-title>
            <source>Clin Nephrol</source>
            <year>1998</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>96</fpage>
            <page-range>96-101</page-range>
            <pub-id pub-id-type="pmid">9524779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27867.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasser</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Melgar</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Longworth</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia.</article-title>
            <source>Am J Med</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>103</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-32</page-range>
            <pub-id pub-id-type="pmid">9236482</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
